[{"Assets_0_Q3_USD":277737000.0,"CommonStockSharesOutstanding_0_Q3_shares":79440700.0,"NetIncomeLoss_1_Q3_USD":-23969000.0,"NetIncomeLoss_3_Q3_USD":-71936000.0,"StockholdersEquity_0_Q3_USD":237704000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]